This bill amends the Childhood Blood Lead Test Act to enhance lead testing requirements for children and pregnant women in Pennsylvania. It mandates that all children receive a blood lead test by the age of two, replacing the previous language that encouraged testing. Additionally, the bill introduces a new definition for "cost-sharing," clarifying the out-of-pocket expenses that insured individuals may incur for health care costs. It also specifies that blood lead tests must be covered by health insurance policies without any cost-sharing, ensuring that families do not face financial barriers to testing.

Furthermore, the bill updates the lead testing requirements for health care providers, emphasizing the necessity of testing for children who have never been tested between the ages of 24 and 72 months. It also stipulates that if a blood lead test indicates an elevated level, a confirmatory test must be conducted in accordance with CDC recommendations. The amendments aim to improve early diagnosis and treatment of lead exposure, thereby enhancing public health outcomes for vulnerable populations.

Statutes/Laws affected:
Printer's No. 988 (Jun 24, 2025): P.L.2135, No.150